Status:
UNKNOWN
Completely Abdominal Approach Laparoscopic Partial Intersphincteric Resection for Rectal Cancer
Lead Sponsor:
Zhongnan Hospital
Conditions:
Rectal Cancer
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The conventional intersphincteric resection (ISR) for low rectal cancer requires a combined abdominal and perineal approach, and followed with a handsewn coloanal anastomosis, which is time consuming ...
Detailed Description
Patients with cT1 to cT2 low rectal cancer are directly operated through completely abdominal approach laparoscopic partial ISR surgery. Patients with cT3 low rectal cancer are firstly treated with st...
Eligibility Criteria
Inclusion
- Biopsy-proven moderate or well differentiated adenocarcinoma
- Rullier classification of low rectal cancer (types Ⅱ: juxta-anal tumor)
- Clinical staging: initially staged as T1 -2 or down staged to T1-2 after neoadjuvant chemoradiotherapy;
Exclusion
- Without signing informed consent, poor compliance
- Unfit for laparoscopy
- Other serious diseases not suitable for participating in this clinical trial
- A degree of preoperative fecal incontinence
- After preoperative neoadjuvant chemoradiotherapy, the sphincter function, sexual function and others involved in this trail are seriously affected
Key Trial Info
Start Date :
July 19 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 19 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04481659
Start Date
July 19 2020
End Date
July 19 2025
Last Update
July 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhongnan Hospital, Wuhan University
Wuhan, Hubei, China, 430071